nanosynth group appoint Andrew Stedman and Peter Gray to the board

nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced the appointments of Andrew Stedman as Chief Financial Officer and Peter Gray as an independent Non-Executive Director of the Company with immediate effect. Both positions will be board roles.

Andrew Stedman was appointed as the Company’s non-board Chief Financial Officer on 7 February 2022. Andrew has considerable experience and a proven track record of driving incremental cash value whilst delivering on strategic growth strategies, across numerous market sectors.  Andrew has previously led commercial finance, transformation, and product launches at listed Company’s such as Ricoh PLC and Dixons Carphone PLC.  Andrew brings the experience of a well-rounded and highly commercial finance leader with substantial M&A and deal exposure, skills closely aligned to our strategic objectives.

Peter Gray has a wealth of experience in corporate and M&A transactions. Peter graduated with degrees in Law and Commerce from Melbourne University in 1984 and then worked in the corporate finance department at Minter Ellison (Melbourne) before moving to Clifford Chance, the leading international law firm. After completing an MBA in Finance, Peter then joined Cavendish Corporate Finance in 1994 which has subsequently merged with small and mid-cap listed corporate finance and broking house finnCap which listed on AIM in December 2018. Peter is currently employed as a partner of finnCap Cavendish a trading name of finnCap Group plc. Peter is also a frequent lecturer and author on the subject of mergers and acquisitions.

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Andrew John Christian Stedman (aged 43):

 Current directorships and/or partnerships:Former directorships and/or partnerships (within the last five years):
Ertominiz LimitedThorin Ltd

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Peter James Gray (aged 61):

 Current directorships and/or partnerships:Former directorships and/or partnerships (within the last five years):
NoneCavendish Corporate Finance (UK) Limited

Peter Gray was previously an LLP member of Cavendish Corporate Finance LLP.

Mark Duffin, Chief Executive of nanosynth Group, commented:

“We are delighted that both Andrew and Peter have agreed to join the Board and, on behalf of all the Directors, we welcome them and very much look forward to working with them. The pair bring extensive experience and I have no doubt that they will quickly become extremely valuable members of the Board.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Nanosynth Group plc

    More articles like this

    Nanosynth Group plc

    Nanotechnology in the nutricosmetics industry

    Nanotechnology for Nutricosmetics Nanocarriers are ubiquitous within nanomedicine; however, with skin quality and health in high demand for consumers, these fields have overlapped. The use of nanotechnology and nanoformulations as delivery systems for improving the performance of active

    Nanosynth Group plc

    Nanotechnology in cosmetics

    Nanotechnology is the science of manipulating atoms and molecules in the nanoscale – 80,000 times smaller than the width of a human hair. The world market for products that contain nanomaterials is expected to reach $2.6 trillion by

    Nanosynth Group plc

    nanosynth group enter funding arrangements with Lanstead

    nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced a conditional subscription to raise £2,942,500 through the issue of 535,000,000 new ordinary shares

    Nanosynth Group plc

    Nanoparticles boost anti-cancer immunity

    The growth of epithelial ovarian cancer, one of the most lethal malignancies, is associated with the presence of tumor-associated macrophages (TAMs), white blood cells that can block the anti-cancer activity of the immune system and immunotherapy. Fortunately, TAMs

    Nanosynth Group plc

    Improving crop resilience with nanoparticles

    Materials that can carry CRISPR gene-editing into plant cells could be key in the fight against global hunger. There were sceptics when Michael Strano and his colleagues published their method for using nanoparticles to alter the biology of

    Nanosynth Group plc

    How silicate nanoparticles help save historic buildings

    Constructions made of porous rock may weather over time. TU Wien (Vienna) researchers have now thoroughly examined how silicate nanoparticles can help save them for the first time. Several historical buildings were made of limestone, such as Vienna’s St. Stephen’s

    Nanosynth Group plc

    Nanoparticles can save historic buildings

    Many historical buildings were built of limestone, such as Vienna’s St. Stephen’s Cathedral. Limestone is easy to work with, but does not withstand weathering well. It consists mainly of calcite minerals that are relatively weakly bound to each

    Nanosynth Group plc

    Role of nanotechnology in management of plant viral diseases

    Plant viral diseases create massive economic damages and endanger the sustainability of agriculture. Nanotechnology is an emerging agronomy technique for plant viral disease control as nanoparticles can be utilized in pest control systems as nano insecticides, medicine delivery

    Nanosynth Group plc

    Nanoparticles can be triggered to release anti-cancer microRNA

    Study shows that nanoparticles release an anti-cancer microRNA inside lung cancer cells when stimulated using an alternating magnetic field. Researchers are pursuing ever-more sophisticated treatments to tackle lung cancer. Traditional chemotherapy can have serious side-effects throughout the body,

    Nanosynth Group plc

    Nanosynth Group “rapid progress is being made”

    Nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced a strategic update further to its notification of 1 June 2022. The business

    Nanosynth Group plc

    Nanosynth AGM to be held on 26 July 2022

    Nanosynth Group plc (LON:NANO) the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, announces that the date of the Company’s AGM has been changed. The Company’s Annual General

    Nanosynth Group plc

    Nanosynth Group new name, new board and new direction

    Nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced its final audited results for the year ended 31 December 2021. The Company

    Nanosynth Group plc

    What are nanoparticles?

    A nanoparticle is a small particle that ranges between 1 to 100 nanometres in size. Undetectable by the human eye, nanoparticles can exhibit significantly different physical and chemical properties to their larger material counterparts. The definition given by

    No more posts to show